Recently, Hangzhou Xiran Medical announced the completion of nearly 100 million yuan in Series A financing, which is another important milestone in the company's development history. This round of financing was led by Legend Capital, with the continuous support of old shareholders Taiyu Investment, Proxima Venture Capital, Daotong Investment and Daoyuan Capital, which fully reflects the market's high recognition of Xiran Medical and its confidence in its future development.
Founded in 2020, Xiran Medical is a technology-based ophthalmic surgery equipment manufacturer, committed to providing one-stop training services for surgeons. In just a few years, with its innovative technology and high-quality services, Xiran Medical has quickly emerged in the ophthalmic surgery equipment market.
With the improvement of people's health awareness and the continuous advancement of medical technology, the ophthalmic surgery market is showing a rapid growth trend. As a result, the market demand for ophthalmic surgical equipment continues to grow, putting forward higher requirements for the performance, safety and ease of use of the equipment. It is precisely by seizing this market opportunity that Xiran Medical has met the diverse needs of physicians and patients through continuous technological innovation and product iteration.
The participation of well-known investment institutions such as Legend Capital will inject new impetus into the development of Xiran Medical. Legend Capital has rich investment experience and resources in the healthcare field, and its addition will help Xiran Medical further expand its market share, enhance its brand influence, and accelerate the company's growth.
It is worth mentioning that the performance of Xiran Medical in the ophthalmic surgery equipment market has attracted much attention. According to Tianyancha data, Xiran Medical has completed multiple rounds of financing in just a few years after its establishment, attracting the attention of many well-known investment institutions. This fully illustrates the strength and market prospects of Xiran Medical in the field of ophthalmic surgical equipment.
In general, the completion of the A round of financing of nearly 100 million yuan marks a new stage in the company's development in the ophthalmic surgery equipment market. With the continuous innovation of technology and the continuous growth of market demand, Xiran Medical is expected to make greater breakthroughs and achievements in the future market competition. We look forward to continuing to leverage our strengths and bring more innovation and value to the field of ophthalmic surgery." (Data support: Tianyancha).